Carbon-Based Nanocarriers for Drug Delivery enlists the latitudes and advancements in the synthesis processes, functionalization, and applications of carbon-based nanomaterials (CBNs) in targeted drug delivery systems (DDSs). It covers the applicability and suitability of CBNs as nanocarriers for efficient drug delivery application via elucidating the recent advancements in CBNs, their functionalized and innovative derivatives, and the relevant case studies. The book explores the necessity, efficacy, toxicological aspects, and challenges for the application of CBN in targeted DDSs. Some of the features of this book are provided as follows:
- Provides elaborative description on significance and adaptability of carbon-based nanomaterial in targeted drug delivery for wide ranges of therapeutics
- Delivers a full-spectrum discussion on drug delivery through carbon-based nanocarriers
- Explores each carbon-based nanocarrier fundamentally for its drug and gene-delivery-related applications
- Describes critical discussion on various toxicological effects over the utilization of these nanocarriers
- Embraces existing as well as novel technologies/methodologies related to the synthesis and functionalization of CBNs, including graphene, graphene oxide, carbon quantum dots, carbon nanotube, fullerene, and smart carbon-based nanocarriers
This book is aimed at researchers and graduate students in materials and pharmaceutical engineering, including drug delivery systems.
1. Fundamentals of carbon-based nanomaterials. 2. Advancement in drug delivery systems. 3. Graphene-based nanocarriers as drug delivery system. 4. Drug delivery with graphene oxide-based nanocarriers. 5. Carbon nanotubes for drug delivery system. 6. Graphene quantum dots for drug delivery. 7. Fullerene-based drug delivery system. 8. Carbon-based nanocomposites for drug delivery. 9. Smart carbon-based nanocarriers for drug delivery. 10. Toxicological studies of carbon-based nanocarriers. 11. Challenges and opportunities of carbon-based nanomaterials as nanocarriers. 12. Journey of nano-drug delivery systems from lab to
clinics: Case studies.